Clinical Trial Update: Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids [Phase 2, Phase 3]

View source ↗

Summary

This update reports a completed Phase 2/3 trial evaluating Mifepristone at 5 mg or 10 mg daily for six months in women with uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Mediterranea Medica S. L. | Conditions: Uterine Fibroids | Phase 2, Phase 3 | Status: COMPLETED